US 9475869
Human antibodies to fel d1 and methods of use thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 9475869 (Human antibodies to fel d1 and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/5252, A61K39/12